These findings significantly advance our understanding of TCM immunomodulation by revealing a precise epigenetic pathway (DNMT1-Foxp3-TSDR) underpinning JPZS’s therapeutic efficacy in SLE. This evidence concerns the gene FOXP3 and systemic lupus erythematosus.